IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,572,667 | +101.6% | 67,014 | -0.4% | 0.00% | – |
| Q2 2023 | $1,276,150 | +30.0% | 67,272 | +6.3% | 0.00% | – |
| Q1 2023 | $981,426 | +98042.6% | 63,277 | +51344.7% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 123 | -76.3% | 0.00% | – |
| Q2 2022 | $2,000 | -98.1% | 520 | -95.8% | 0.00% | – |
| Q4 2021 | $105,000 | – | 12,423 | +23339.6% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 53 | -99.8% | 0.00% | – |
| Q2 2021 | $321,000 | -68.1% | 30,410 | -51.5% | 0.00% | – |
| Q1 2021 | $1,006,000 | -45.7% | 62,697 | +56.3% | 0.00% | – |
| Q4 2020 | $1,853,000 | -17.8% | 40,116 | -37.4% | 0.00% | -100.0% |
| Q3 2020 | $2,254,000 | +114.9% | 64,047 | +48.7% | 0.00% | – |
| Q2 2020 | $1,049,000 | – | 43,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |